Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Orphan drug source : Jaguarhealth.gcs-web.com save search
Jaguar Health’s Subsidiary Napo EU Changes Name to Napo Therapeutics, Reflecting the Italian Company’s Focus on Rare Diseases & Orphan Drugs
Published: 2021-12-20 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | $0.1771 7.4% 6.94% 2.8M
|
Health Technology
|
| O: 2.8%
H: 6.36%
C: 4.55%
health drug therapeutics disease orphan drug rare
European Medicines Agency Grants Orphan Drug Designation for Crofelemer to Napo EU, Jaguar Health’s Italian Subsidiary, for Short Bowel Syndrome
Published: 2021-12-13 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | $0.1771 7.4% 6.94% 2.8M
|
Health Technology
|
| O: -13.48%
H: 0.0%
C: 0.0%
health europe drug orphan drug syndros crofelemer granted grant designation
Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary for Crofelemer for Short Bowel Syndrome with Intestinal Failure Accepted for Review by European Medicines Agency
Published: 2021-09-15 (Crawled : 00:20) - jaguarhealth.gcs-web.com
JAGX | $0.1771 7.4% 6.94% 2.8M
|
Health Technology
|
| O: 2.13%
H: 2.5%
C: -1.25%
orphan drug europe test drug syndros crofelemer designation
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
AGBA | News | $1.4 250.0% 35M
|
Finance
ZCMD | $2.18 50.35% 24M
|
Commercial Services
RWOD | $12.0 50.06% 3.9M
|
n/a
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
INDO | $4.9 20.1% 2.2M
|
Energy Minerals
NURO | $4.32 18.36% 66K
|
Health Technology
HUBC | $1.52 17.83% 4.7M
|
n/a
MCB 4 | $38.545 16.45% 34K
|
Finance
BHAT | $1.06 11.58% 9.3K
|
Consumer Durables
Your saved searches
Save your searches and get alerts when important news are released.